A New Base for Bone Cancer


When pathologist Adrienne Flanagan joined the UK's Royal National Orthopaedic Hospital in 2002, the first version of the human genome was brand new. At the time, she received a piece of advice: Bank as many tumor samples as you can; they'll be needed for future genomic studies. "So, I biobanked almost any tumor that I could lay my hands on since 2002," Flanagan says. "And the person who gave me that advice is a chap called Professor Michael Stratton, who is now the director of the Wellcome Trust Sanger Institute."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.